BRK.B
34
-2
MCK
66
-4
MPC
47
3
ACN
42
2
AN
47
3
FITB
53
3
WAT
38
2
MS
62
5
CHD
56
-2
UNM
63
2
CTAS
59
-5
EA
46
-3
APD
32
-5
PWR
61
-4
DO
47
-2
CSX
50
2
SBUX
35
2
EXPD
53
-5
ZTS
58
-2
SE
49
-6
BRK.B
34
-2
MCK
66
-4
MPC
47
3
ACN
42
2
AN
47
3
FITB
53
3
WAT
38
2
MS
62
5
CHD
56
-2
UNM
63
2
CTAS
59
-5
EA
46
-3
APD
32
-5
PWR
61
-4
DO
47
-2
CSX
50
2
SBUX
35
2
EXPD
53
-5
ZTS
58
-2
SE
49
-6
Financhill
Back

Keros Therapeutics Vs. BridgeBio Pharma Industry Stock Comparison

Sell
27

KROS
Keros Therapeutics

Last Price:
45.71
Seasonality Move:
-4.71%
Sell
37

BBIO
BridgeBio Pharma

Last Price:
25.33
Seasonality Move:
19.32%
Sell
27
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $45.70. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
BridgeBio Pharma (BBIO) is a Sell

Is BridgeBio Pharma a Buy, Sell or Hold?

  • The current BridgeBio Pharma [BBIO] share price is $25.41. The Score for BBIO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • BBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $45.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.

BBIO Stock Price Chart

What is BridgeBio Pharma's stock price today?

  • The BridgeBio Pharma share price today is $25.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing slight buying pressure.

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.79 Sell
Relative Strength Index (14 RSI): 38.41 Sell
Chaikin Money Flow: 239305 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.72 - 49.1) Sell
Bollinger Bands (100): (49.87 - 64.91) Sell

BBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.92 Sell
Relative Strength Index (14 RSI): 43.82 Sell
Chaikin Money Flow: 429618 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.44 - 28.72) Sell
Bollinger Bands (100): (25.8 - 32.34) Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.61 Buy
20-day SMA: 47.29 Sell
50-day SMA: 51.65 Sell
200-day SMA: 47.07 Sell
8-day EMA: 45.93 Sell
20-day EMA: 47.34 Sell
50-day EMA: 50.89 Sell
200-day EMA: 50 Sell

BBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.32 Buy
20-day SMA: 26.85 Sell
50-day SMA: 27.26 Sell
200-day SMA: 30.25 Sell
8-day EMA: 25.34 Buy
20-day EMA: 26.42 Sell
50-day EMA: 27.49 Sell
200-day EMA: 28.25 Sell

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

BridgeBio Pharma Earnings Growth & BBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.30 per share, an increase this year of $2.47 per share, and a decrease next year of $2.17 per share.

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BridgeBio Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):